February 4, 2025- McKesson Corporation announced that it signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC (PRISM Vision), a premier provider of general ophthalmology and retina management services, from Quad-C. McKesson will purchase an 80% interest for approximately $850 million. PRISM Vision physicians will continue to retain a 20% interest in PRISM Vision.
This transaction will enable McKesson to deliver on several key strategic objectives:
Develop a leading retinal and ophthalmology platform, expanding McKesson’s differentiated value proposition, clinical services and distribution offerings. PRISM affiliated practices include more than 180 providers, 91 office locations and seven ambulatory surgery centers
- Expand data and analytics capabilities
- Further innovative investment in clinical research opportunities
- Deepen biopharma partnerships